Connecticut House Bill HB05445

Connecticut 2019 Regular Session

• Introduced: 1/16/19
• Refer: 1/16/19

Caption

An Act Establishing A Registry Of Data On Amniotic Fluid Embolism Occurrences.

Impact

The implementation of HB 5445 may significantly impact state laws regarding healthcare data collection and management. By forming a formal registry for AFE occurrences, the bill seeks to enhance tracking and research capabilities surrounding this rare but serious complication in pregnancy. This reformation in data handling practices is anticipated to contribute positively to public health initiatives, prompting further research and improved treatment protocols related to amniotic fluid embolism.

Summary

House Bill 5445, titled 'An Act Establishing A Registry Of Data On Amniotic Fluid Embolism Occurrences,' aims to establish a comprehensive registry managed by the Department of Public Health. This registry is intended to compile non-personally identifiable data regarding incidents related to amniotic fluid embolism (AFE). The bill mandates that hospitals collect and submit relevant data concerning the diagnosis and treatment of AFE to this registry, promoting better research and understanding of this medical condition.

Contention

While the bill presents benefits in terms of data collection and public health enhancement, it may also raise concerns regarding data privacy and the administrative burden on hospitals tasked with reporting. Stakeholders may debate the implications of mandated reporting requirements, weighing the benefits of extensive data collection against potential logistical challenges and resource allocation for hospitals. Moreover, the efficacy of non-personally identifiable data in influencing medical outcomes could also be a point of contention among healthcare professionals and policymakers alike.